Evidence map›Paper›PMID 29256084›Full record

ArticleExtremophiles : life under extreme conditions2018

Fusion with the cold-active esterase facilitates autotransporter-based surface display of the 10th human fibronectin domain in Escherichia coli.

L E Petrovskaya, A V Zlobinov, L N Shingarova, E F Boldyreva, S Sh Gapizov, K A Novototskaya-Vlasova, E M Rivkina, D A Dolgikh, M P Kirpichnikov

Abstract read
PubMed Publisher
In one paragraph

Article in Extremophiles : life under extreme conditions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

L E PetrovskayaShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation. lpetr65@yahoo.com.
A V ZlobinovShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation.
L N ShingarovaShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation.
E F BoldyrevaShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation.
S Sh GapizovShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation.
K A Novototskaya-VlasovaInstitute of Physicochemical and Biological Problems in Soil Science, Russian Academy of Sciences, 142290, Pushchino, Moscow Region, Russian Federation.
E M RivkinaInstitute of Physicochemical and Biological Problems in Soil Science, Russian Academy of Sciences, 142290, Pushchino, Moscow Region, Russian Federation.
D A DolgikhShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation. dolgikh@nmr.ru.
M P KirpichnikovShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya, 16/10, 117997, Moscow, Russian Federation.
Institute of Bioorganic Chemistry · RUInstitute of Physical-Chemical and Biological Problems in Soil Science · RULomonosov Moscow State University · RU

Funding

RF President Grant for Scientific Schools SS-8384.2016.4Russian Academy of Sciences Cellular Biology"Russian Academy of Sciences Program "MolecularRussian Foundation for Basic Research 15-04-07772aRussian Foundation for Basic Research 16-04-00717a
6 · The paper itself

Abstract

Cell surface display is a popular approach for the construction of whole-cell biocatalysts, live vaccines, and screening of combinatorial libraries. To develop a novel surface display system for the popular scaffold protein 10th human fibronectin type III domain (

Indexed as

Cell MembraneCold TemperatureEscherichia coliEsterasesFibronectinsHumansPsychrobacterRecombinant ProteinsType V Secretion SystemsEsterasesFibronectinsfibronectin type III like peptide, humanRecombinant ProteinsType V Secretion Systems10th human fibronectin type III domainAutotransporterCell surface displayCold-active esterasePermafrostPsychrobacter cryohalolentis K5T

Identifiers

PMID29256084
OpenAlexW2775419558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.